{"filing":{"accession_number":"0001437749-26-026769","cik":"0000724004","ticker":"MLAB","company_name":"MESA LABORATORIES INC /CO/","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"mlab20260807_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/724004/000143774926026769/mlab20260807_8k.htm"},"events":[{"id":26511,"run_id":24097,"accession_number":"0001437749-26-026769","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Mesa Laboratories issued a press release on August 10, 2026 disclosing quarterly financial results for the three months ended June 30, 2026 (1Q27). The filing includes detailed revenue, operating income, net income, and divisional performance metrics, along with non-GAAP reconciliations and management commentary. This is a standard earnings release disclosure under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1.","company_name":"MESA LABORATORIES INC /CO/","ticker":"MLAB","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27663,"accession_number":"0001437749-26-026769","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Mesa Laboratories issued a press release on August 10, 2026 disclosing quarterly financial results for the three months ended June 30, 2026 (1Q27). The filing includes detailed revenue, operating income, net income, and divisional performance metrics, along with non-GAAP reconciliations and management commentary. This is a standard earnings release disclosure under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:05:05.781646+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27663,"accession_number":"0001437749-26-026769","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Mesa Laboratories issued a press release on August 10, 2026 disclosing quarterly financial results for the three months ended June 30, 2026 (1Q27). The filing includes detailed revenue, operating income, net income, and divisional performance metrics, along with non-GAAP reconciliations and management commentary. This is a standard earnings release disclosure under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:05:05.781646+00:00","company_name":"MESA LABORATORIES INC /CO/","ticker":"MLAB","filing_date":"2026-08-10"}]}